XML 84 R73.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Schedule of Activity in Contingent Consideration [Roll Forward]  
Balance at beginning of period $ 375.0
Payments 22.9
Reclassifications 0.0
Accretion expense 11.5
Fair value loss 15.5
Balance at end of period 379.1
Biocon Biologics  
Schedule of Activity in Contingent Consideration [Roll Forward]  
Balance at beginning of period 221.2
Balance at end of period 228.4
Other Current Liabilities [Member]  
Schedule of Activity in Contingent Consideration [Roll Forward]  
Balance at beginning of period 64.4
Payments 22.9
Reclassifications 22.2
Accretion expense 0.0
Fair value loss 0.0
Balance at end of period 63.7
Other long-term obligations  
Schedule of Activity in Contingent Consideration [Roll Forward]  
Balance at beginning of period 310.6
Payments 0.0
Reclassifications (22.2)
Accretion expense 11.5
Fair value loss 15.5
Balance at end of period $ 315.4